U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
113011113011Effects of a Program of Physical Exercise and Electrotherapy on Muscle Strength in Subjects of the Fourth AgeCompletedNo Results AvailableGeriatric Assessment|Muscle Strength|Postural Balance|Body Mass IndexOther: No intervention|Other: Strong progressive strengthening exercises of lower limbs|Other: Electrotherapy|Other: Electrotherapy+weightshttps://ClinicalTrials.gov/show/NCT01086592
113012113012Balloon Elution and Late Loss Optimization (BELLO) StudyActive, not recruitingNo Results AvailableCoronary Artery DiseaseDevice: IN.PACT Falcon paclitaxel eluting balloon (Drug eluting balloon)|Device: Taxus (Paclitaxel eluting stent)https://ClinicalTrials.gov/show/NCT01086579
113013113013Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 VaccinesCompletedNo Results AvailableInfluenzaBiological: Inactivated Influenza A/H5N1/Indonesia/05/05 (clade 2)https://ClinicalTrials.gov/show/NCT01086566
1130141130149 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's DiseaseCompletedNo Results AvailableCrohn´s DiseaseDrug: budesonide|Drug: budesonidehttps://ClinicalTrials.gov/show/NCT01086553
113015113015Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)RecruitingNo Results AvailableSystemic Sclerosis-Associated Pulmonary Arterial HypertensionBiological: Rituximab|Other: Placebohttps://ClinicalTrials.gov/show/NCT01086540
113016113016Genotype Stratified Pharmacokinetic Study of MontelukastRecruitingNo Results AvailableAsthmaDrug: 10 mg tablet of montelukast (Singulair)https://ClinicalTrials.gov/show/NCT01086527
113017113017Digital Mammography for the Detection and Preoperative Staging of Breast CancerCompletedNo Results AvailableBreast CancerProcedure: Dual Energy Contrast Enhanced Digital Mammography (DE CEDM)https://ClinicalTrials.gov/show/NCT01086514
113018113018ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic PatientsCompletedNo Results AvailableEpilepsyhttps://ClinicalTrials.gov/show/NCT01086501
113019113019Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal CarcinomaRecruitingNo Results AvailableNasopharyngeal CarcinomaDrug: FOSCANhttps://ClinicalTrials.gov/show/NCT01086488
113020113020D-Cycloserine and Social Skills Training in Autism Spectrum DisordersCompletedNo Results AvailableAutistic Disorder|Asperger's Disorder|Pervasive Developmental Disorder NOSDrug: D-cycloserine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01086475
113021113021Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633CompletedNo Results AvailableAsthmaDrug: GSK2239633https://ClinicalTrials.gov/show/NCT01086462
113022113022Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese AdultsCompletedNo Results AvailableHerpes ZosterBiological: Herpes Zoster Vaccine GSK 1437173Ahttps://ClinicalTrials.gov/show/NCT01086449
113023113023Study to Evaluate the Safety of Rotarixâ„¢ in Chinese ChildrenCompletedNo Results AvailableRotavirus GastroenteritisBiological: Rotarix â„¢|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01086436
113024113024Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hibâ„¢ VaccineCompletedNo Results AvailablePoliomyelitis|Haemophilus Influenzae Type b Disease|Diphtheria|Pertussis|TetanusBiological: Infanrix-IPV/Hibâ„¢|Biological: Infanrix Hibâ„¢|Biological: Poliorixâ„¢https://ClinicalTrials.gov/show/NCT01086423
113025113025Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) AxisCompletedHas ResultsAsthmaDrug: Placebo Inhalation Powder|Drug: Fluticasone Furoate/GW642444 Inhalation Powder|Drug: Fluticasone Furoate/GW642444 Inhalation Powder|Drug: Placebo Oral Capsule|Drug: Prednisolone Oral Capsulehttps://ClinicalTrials.gov/show/NCT01086410
113026113026Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired PneumoniaCompletedNo Results AvailablePneumonia, Pneumococcal|Vaccines, PneumococcalProcedure: Urine sample collectionhttps://ClinicalTrials.gov/show/NCT01086397
113027113027Asthma Exacerbation StudyCompletedHas ResultsAsthmaDrug: Fluticasone Furoate/GW642444|Drug: Fluticasone furoatehttps://ClinicalTrials.gov/show/NCT01086384
113028113028Rhythmic Auditory Stimulation and Walking Performance in Multiple Sclerosis (MS) PatientsWithdrawnNo Results AvailableGait Disturbance in Multiple Sclerosis PatientsOther: Rhythmic auditory stimulation|Other: Walking exercisehttps://ClinicalTrials.gov/show/NCT01086371
113029113029Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?RecruitingNo Results AvailableWorkplace Migraine TreatmentDrug: Usual prescribed triptan|Drug: Treximet for migraine treatmenthttps://ClinicalTrials.gov/show/NCT01086358
113030113030Radiosurgery Plus Bevacizumab in GlioblastomaTerminatedNo Results AvailableGlioblastoma|Gliosarcoma|Brain TumorRadiation: radiosurgery|Biological: bevacizumab|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT01086345
113031113031Evaluation of Nelfinavir and Chemoradiation for Pancreatic CancerActive, not recruitingNo Results AvailablePancreatic NeoplasmsDrug: Nelfinavir|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT01086332
113032113032Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentsActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 2https://ClinicalTrials.gov/show/NCT01086319
113033113033Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 2https://ClinicalTrials.gov/show/NCT01086306
113034113034Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentsActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 2https://ClinicalTrials.gov/show/NCT01086293
113035113035Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic TreatmentsActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 2https://ClinicalTrials.gov/show/NCT01086280
113036113036Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: BMS-908662|Drug: BMS-908662|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT01086267
113037113037SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung CancerCompletedNo Results AvailableNon-small Cell Lung Cancer Stage IVDrug: Iniparib|Drug: gemcitabine|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT01086254
113038113038Tomosynthesis in Screening MammographyActive, not recruitingNo Results AvailableBreast Density >25%Procedure: 2D Mammogram|Procedure: Tomosynthesishttps://ClinicalTrials.gov/show/NCT01086241
113039113039XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for JapanActive, not recruitingNo Results AvailableAngina|Chronic Coronary Occlusion|Stent Thrombosis|Vascular Disease|Myocardial Ischemia|Coronary Artery Stenosis|Coronary Disease|Coronary Artery Disease|Coronary RestenosisDevice: XIENCE V / PROMUS stenthttps://ClinicalTrials.gov/show/NCT01086228
113040113040Registry of AngioJet Use in the Peripheral Vascular SystemCompletedHas ResultsPeripheral Vascular Disease|Embolism and Thrombosis|Venous Thrombosishttps://ClinicalTrials.gov/show/NCT01086215

* Görseller ve İçerik tekif hakkına sahip olabilir